REHOVOT, Israel, March 6,
2023 /PRNewswire/ -- Ag Plenus Ltd., an innovative
company designing effective, sustainable crop protection products
by leveraging computational biology and chemistry, and a subsidiary
of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today announced that
representatives from its management will be attending and
participating at the World Agri-Tech Conference in San Francisco, taking place between
March 14-15, 2023.
AgPlenus will be represented at the conference by Merav Beiman, VP R&D, and Mirit Ram, VP Portfolio Management.
The World Agri-Tech Innovation Summit has become the annual
meeting place for the global agtech ecosystem. Over 2,000 growers,
agribusiness leaders, technology pioneers and investors come
together to exchange insights, be inspired, and identify future
partners.
Investors or analysts attending the conference and wish to meet
with the management of AgPlenus, are welcome to contact the
AgPlenus team directly or reach out through World Agri-Tech
conference channels.
About AgPlenus Ltd.
AgPlenus is a platform company designing effective and
sustainable crop protection products. At AgPlenus, we
are solving pesticide resistance by infusing the discovery process
with predictive biology and artificial
intelligence. AgPlenus leverages the ChemPass
AI tech-engine, licensed from Evogene, to
discover and bring to market effective and sustainable
crop protection products. Our target-based approach allows us
to reduce risk and increase efficiency, so that we can deliver
on our promise to defeat global pesticide resistance. AgPlenus has
ongoing collaborations with industry leader such as Corteva.
AgPlenus is a subsidiary of Evogene Ltd.
For more information, please visit www.agplenus.com
About Evogene Ltd.:
Evogene (Nasdaq: EVGN, TASE: EVGN) is a computational biology
company aiming to revolutionize the development of life-science
based products by utilizing cutting edge technologies to increase
the probability of success while reducing development time and
cost. Evogene established three unique tech-engines -
MicroBoost AI, ChemPass
AI and GeneRator AI – leveraging Big Data
and Artificial Intelligence and incorporating deep
multidisciplinary understanding in life sciences. Each
tech-engine is focused on the discovery and development of
products based on one of the following core components: microbes
(MicroBoost AI), small molecules (ChemPass AI), and
genetic elements (GeneRator AI).
Evogene uses its tech-engines to develop products through
subsidiaries and strategic partnerships. Evogene's subsidiaries
currently utilize the tech-engines to develop human
microbiome-based therapeutics by Biomica, ag-biologicals by
Lavie Bio, ag-chemicals by AgPlenus,
medical cannabis products by Canonic and castor varieties, for the
biofuel and other industries, by Casterra.
For more information, please visit www.evogene.com
Contacts
|
|
Merav Beiman, VP
R&D
E:
merav.beiman@agplenus.com
T: +972-8-931 1900
|
Mirit Ram, VP Portfolio
Managment
E:
mirit.ram@agplenus.com
T: +972-8-931 1900
|
Kenny Green, Investor
Relations
E:
kenny.green@evogene.com
T: +1 212 378
8040
|
|
Logo:
https://mma.prnewswire.com/media/1334691/AgPlenus.jpg
Logo: https://mma.prnewswire.com/media/1947468/Evogene.jpg
View original
content:https://www.prnewswire.com/news-releases/agplenus-to-attend-world-agri-tech-conference-in-san-francisco-301763159.html
SOURCE AgPlenus Ltd.